Many studies have demonstrated that the concentration of CHI3L1 in CNS, CSF, and plasma in AD patients is elevated, and according to some of them, it can help differentiate AD from frontotemporal dementia (FTD) (Hampel et al. This evidence concerns the gene CHI3L1 and frontotemporal dementia.